Insider Cluster (2 insiders) ·Filed Jun 30, 2026

IRON

Disc Medicine, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $86K total
Actionable Insight • Neutral

The insider sales are routine and negligible. The debt amendment extends cash runway into 2028, a modest positive for a pre-revenue biotech. No actionable trading signal from the cluster alone — monitor upcoming clinical catalysts for IRON.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
IRON ▼ -11.35% at T+60d
NEUTRAL call ✗ call lost -11.35% · α vs SPY -14.23% · entry $74.95 → $66.44
Entry anchored
Jun 30, 03:59 PM ET
via exchange tick
T+1d
+1.75%
call +1.75% · α +1.88%
$76.26
settled 3mo ago
T+5d
+6.42%
call +6.42% · α +6.16%
$79.76
settled 3mo ago
T+20d
-1.71%
call -1.71% · α +0.48%
$73.67
settled 2mo ago
T+60d
-11.35%
call -11.35% · α -14.23%
$66.44
settled 8d ago

Price Chart

Loading chart...

Executive Summary

Two C-suite insiders at Disc Medicine (IRON) sold a total of $209K in open-market shares over a 4-day window, all via same-day option exercises. The sales represent just 0.0075% of the $2.8B market cap, making them trivial. Concurrently, the company filed an 8-K amending its Hercules loan to draw $30M and extend draw periods through 2028, modestly improving liquidity. The insider activity carries no material signal.

Key Financial Metrics

Direction
selling
Total Value
$209.3K
Insiders
2

Key Facts

  • Total open-market sales of $209K by CLO Khara Rahul and COO Jonathan Yu over June 26–29, 2026
  • All sales were same-day option exercises (exercise prices $0–$14.69) — routine liquidity events
  • Sales represent ~0.0075% of IRON's $2.8B market cap, well below the 0.1% materiality threshold
  • On June 30, 2026, Disc Medicine filed an 8-K amending its Hercules loan: $30M immediate drawdown, extended draw periods through 2028, and relaxed minimum cash covenant to July 2028

Financial Impact

Insider sales of $209K are immaterial relative to $2.8B market cap; debt amendment provides up to $30M additional liquidity

cashdebt

Risk Factors

  • Insider sales are small and likely tax-driven; no bearish signal
  • Debt amendment increases leverage but extends runway — neutral for equity

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (19 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IRON-1782856303873
20 reports for IRON
Performance horizon
67% Hit rate 6 of 9 directional calls best @ T+60▲ +17.13%Jun 9, 2026
Filters
Rows
Reports for IRON — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
8-K
BULLISH ★ 7/10
$74.14 $69.18▼ −6.69%▼ −6.19%$64.48 (−13.03%)
Sep 9, 2026
22d ago
Press Release
BULLISH ★ 7/10
$74.14 $69.18▼ −6.69%▼ −6.19%$64.48 (−13.03%)
Sep 3, 2026
28d ago
Insider Cluster
BEARISH ★ 5/10
$79.23 $68.92▲ +13.01%▲ +11.80%$64.48 (+18.62%)
Sep 2, 2026
29d ago
144
NEUTRAL ★ 2/10
$79.37 $70.06▼ −11.73%▼ −10.58%$64.48 (−18.76%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$82.55 $79.37▼ −3.85%▼ −4.12%$64.48 (−21.89%)
Aug 18, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$80.32 $82.67▲ +2.93%▲ +3.31%$64.48 (−19.72%)
Aug 14, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$80.05 $80.94▲ +1.11%▲ +2.30%$64.48 (−19.45%)
Jul 30, 2026
9w ago
8-K
BULLISH ★ 7/10
$79.21 $77.44▼ −2.23%▼ −5.86%$64.48 (−18.60%)
Jul 30, 2026
9w ago
Press Release
BULLISH ★ 7/10
$79.21 $77.44▼ −2.23%▼ −5.86%$64.48 (−18.60%)
Jul 14, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$76.02 $74.32▼ −2.24%▼ −1.26%$64.48 (−15.18%)
Showing 10 of 20

US Market Status

Market Open — Closes in 3h 57m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 30, 2026